"beta-Lactam Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.
| Descriptor ID |
D018440
|
| MeSH Number(s) |
G06.099.225.500 G06.225.347.500 G07.690.773.984.269.347.500
|
| Concept/Terms |
beta-Lactam Resistance- beta-Lactam Resistance
- beta Lactam Resistance
- beta-Lactamase Resistant
- Resistant, beta-Lactamase
- beta Lactamase Resistant
- beta-Lactam Resistant
- beta Lactam Resistant
- beta-Lactamase Resistance
- Resistance, beta-Lactamase
- beta Lactamase Resistance
|
Below are MeSH descriptors whose meaning is more general than "beta-Lactam Resistance".
Below are MeSH descriptors whose meaning is more specific than "beta-Lactam Resistance".
This graph shows the total number of publications written about "beta-Lactam Resistance" by people in this website by year, and whether "beta-Lactam Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "beta-Lactam Resistance" by people in Profiles.
-
Adler A, Katz DE, Marchaim D. The Continuing Plague of Extended-spectrum ?-lactamase-producing Enterobacteriaceae Infections. Infect Dis Clin North Am. 2016 06; 30(2):347-375.
-
Bae D, Cheng CM, Khan AA. Characterization of extended-spectrum ?-lactamase (ESBL) producing non-typhoidal Salmonella (NTS) from imported food products. Int J Food Microbiol. 2015 Dec 02; 214:12-17.
-
Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother. 2010 May; 54(5):2010-6.
-
Hook EW, McCormack WM, Martin D, Jones RB, Bean K, Maroli AN. Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group. Antimicrob Agents Chemother. 1997 Aug; 41(8):1843-5.